Is Global Medical Stock a Good Investment?
Global Medical Investment Advice | GMRE |
- Examine Global Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Global Medical's leadership team and their track record. Good management can help Global Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Diversified REITs space and any emerging trends that could impact Global Medical's business and its evolving consumer preferences.
- Compare Global Medical's performance and market position to its competitors. Analyze how Global Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Global Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Global Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Global Medical REIT stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Global Medical REIT is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Global Medical Stock
Researching Global Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 63.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.23. Some equities with similar Price to Book (P/B) outperform the market in the long run. Global Medical REIT recorded a loss per share of 0.02. The entity last dividend was issued on the 20th of September 2024. The firm had 1:400 split on the 17th of November 2014.
To determine if Global Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Global Medical's research are outlined below:
| Global Medical REIT generated a negative expected return over the last 90 days | |
| About 63.0% of the company shares are owned by institutional investors | |
| On 8th of October 2024 Global Medical paid $ 0.21 per share dividend to its current shareholders | |
| Latest headline from gurufocus.com: Global Medical REIT Inc Q3 2024 Earnings Call Highlights Navigating Market Challenges ... |
Global Medical Quarterly Cash And Short Term Investments |
|
Global Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Global Medical REIT. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Global Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Global Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Global Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-06 | 2024-09-30 | 0.02 | 0.03 | 0.01 | 50 | ||
2024-05-07 | 2024-03-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2023-05-03 | 2023-03-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2022-05-04 | 2022-03-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2022-02-28 | 2021-12-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2021-08-03 | 2021-06-30 | 0.05 | 0.04 | -0.01 | 20 | ||
2021-05-05 | 2021-03-31 | 0.04 | 0.03 | -0.01 | 25 | ||
2020-05-06 | 2020-03-31 | 0.04 | 0.03 | -0.01 | 25 |
Know Global Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Global Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Global Medical REIT backward and forwards among themselves. Global Medical's institutional investor refers to the entity that pools money to purchase Global Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 868.4 K | Charles Schwab Investment Management Inc | 2024-09-30 | 853.1 K | Nuveen Asset Management, Llc | 2024-06-30 | 814.2 K | Phocas Financial Corp | 2024-06-30 | 669.6 K | State Of New Jersey Common Pension Fd D | 2024-09-30 | 637.8 K | Northern Trust Corp | 2024-09-30 | 568 K | Pacific Ridge Capital Partners, Llc | 2024-09-30 | 539.9 K | Keeley-teton Advisors, Llc | 2024-06-30 | 471.9 K | Cutler Capital Management | 2024-09-30 | 448.9 K | Vanguard Group Inc | 2024-09-30 | 6.4 M | Blackrock Inc | 2024-06-30 | 5.3 M |
Global Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 602.82 M.Market Cap |
|
Global Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.04 | 0.03 |
Determining Global Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Global Medical is a good buy. For example, gross profit margin measures Global Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Global Medical's profitability and make more informed investment decisions.
Please note, the presentation of Global Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Global Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Global Medical's management manipulating its earnings.
Evaluate Global Medical's management efficiency
Global Medical REIT has return on total asset (ROA) of 0.0171 % which means that it generated a profit of $0.0171 on every $100 spent on assets. This is way below average. Global Medical's management efficiency ratios could be used to measure how well Global Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Global Medical's Return On Capital Employed is projected to slightly grow based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.02, whereas Return On Equity is forecasted to decline to 0.03. At present, Global Medical's Other Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 71 M, whereas Non Currrent Assets Other are projected to grow to (424.6 K).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 9.24 | 12.97 | |
| Tangible Book Value Per Share | 8.42 | 11.70 | |
| Enterprise Value Over EBITDA | 12.04 | 12.86 | |
| Price Book Value Ratio | 1.25 | 2.13 | |
| Enterprise Value Multiple | 12.04 | 12.86 | |
| Price Fair Value | 1.25 | 2.13 | |
| Enterprise Value | 18 M | 18.9 M |
The strategic initiatives led by Global Medical's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Dividend Yield 0.0972 | Forward Dividend Yield 0.0972 | Forward Dividend Rate 0.84 | Beta 1.281 |
Basic technical analysis of Global Stock
As of the 22nd of November, Global Medical retains the Market Risk Adjusted Performance of (0.13), risk adjusted performance of (0.03), and Standard Deviation of 1.3. Global Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Global Medical REIT information ratio and potential upside to decide if Global Medical is priced fairly, providing market reflects its last-minute price of 8.73 per share. Given that Global Medical REIT has information ratio of (0.13), we strongly advise you to confirm Global Medical REIT's regular market performance to make sure the company can sustain itself at a future point.Global Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Global Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Global Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Global Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Danica Holley over a month ago Acquisition by Danica Holley of 6191 shares of Global Medical subject to Rule 16b-3 | ||
Ronald Marston over three months ago Acquisition by Ronald Marston of 9316 shares of Global Medical subject to Rule 16b-3 | ||
Roscoe Moore over six months ago Acquisition by Roscoe Moore of 5000 shares of Global Medical subject to Rule 16b-3 | ||
Robert Kiernan over six months ago Acquisition by Robert Kiernan of 27434 shares of Global Medical subject to Rule 16b-3 | ||
Robert Kiernan over six months ago Acquisition by Robert Kiernan of 38860 shares of Global Medical subject to Rule 16b-3 | ||
Jamie Barber over six months ago Acquisition by Jamie Barber of 20725 shares of Global Medical subject to Rule 16b-3 | ||
Zh Usa Llc over a year ago Purchase by Zh Usa Llc of tradable shares of Global Medical | ||
Robert Kiernan over a year ago Acquisition by Robert Kiernan of 27422 shares of Global Medical subject to Rule 16b-3 |
Global Medical's Outstanding Corporate Bonds
Global Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Global Medical REIT uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Global bonds can be classified according to their maturity, which is the date when Global Medical REIT has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| GLOBAL PARTNERS LP Corp BondUS37954FAG90 | View | |
| US37954FAJ30 Corp BondUS37954FAJ30 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| US37959EAA01 Corp BondUS37959EAA01 | View | |
| GL 48 15 JUN 32 Corp BondUS37959EAB83 | View | |
| US37959GAA58 Corp BondUS37959GAA58 | View | |
| US37959GAC15 Corp BondUS37959GAC15 | View |
Understand Global Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Global Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 1.01 | |||
| Coefficient Of Variation | (2,374) | |||
| Standard Deviation | 1.3 | |||
| Variance | 1.68 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 6.41 | |||
| Value At Risk | (2.36) | |||
| Potential Upside | 1.78 | |||
| Skewness | 0.1487 | |||
| Kurtosis | 0.4275 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 1.01 | |||
| Coefficient Of Variation | (2,374) | |||
| Standard Deviation | 1.3 | |||
| Variance | 1.68 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 6.41 | |||
| Value At Risk | (2.36) | |||
| Potential Upside | 1.78 | |||
| Skewness | 0.1487 | |||
| Kurtosis | 0.4275 |
Consider Global Medical's intraday indicators
Global Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Global Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Global Medical Corporate Filings
8K | 15th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 12th of August 2024 Other Reports | ViewVerify | |
8K | 6th of June 2024 An amendment to a previously filed Form 8-K | ViewVerify |
Global Stock media impact
Far too much social signal, news, headlines, and media speculation about Global Medical that are available to investors today. That information is available publicly through Global media outlets and privately through word of mouth or via Global internal channels. However, regardless of the origin, that massive amount of Global data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Global Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Global Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Global Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Global Medical alpha.
Global Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Global Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Global Medical Corporate Directors
| Henry Cole | Lead Independent Director | Profile | |
| Matthew Cypher | Independent Director | Profile | |
| Huiqi Zhang | Director | Profile | |
| Roscoe Moore | Independent Director | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.84 | Earnings Share (0.02) | Revenue Per Share 2.082 | Quarterly Revenue Growth (0.04) |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Global Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.